Patent details

EP1248622 Title: Pharmaceutical composition comprising a metabolite of buspirone

Basic Information

Publication number:
EP1248622
PCT Application Number:
PCT/US/2000/028800
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP009736364
PCT Publication Number:
WO/2001/052853
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Pharmaceutical composition comprising a metabolite of buspirone
French Title of Invention:
Composition pharmaceutique comprenant un metabolite de la buspirone
German Title of Invention:
Pharmazeutische Zusammensetzung enthaltend einen Metabolit von Buspirone
SPC Number:

Dates

Filing date:
18/10/2000
Grant date:
27/07/2005
EP Publication Date:
27/07/2005
PCT Publication Date:
26/07/2001
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/10/2002
EP B1 Publication Date:
27/07/2005
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
18/10/2005
Expiration date:
18/10/2020
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/10/2000
 
 

Name:
Bristol-Myers Squibb Company
Address:
P.O. Box 4000, Route 206 and Provinceline Road, Princeton, NJ 08543-4000, United States (US)

Inventor

Name:
MAYOL Robert, F.
Address:
United States (US)

Priority

1

Priority Number:
484161
Priority Date:
18/01/2000
Priority Country:
United States (US)

2

Priority Number:
588221
Priority Date:
06/06/2000
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/505;
Filing date Document type Number of pages